Peripheral blood derived cell trafficking for cardiac regeneration

Simone Post1, Marie-José Goumans, Pieter A Doevendans

  • 1Laboratory Experimental Cardiology, Division Heart & Lungs, University Medical Centre Utrecht, the Netherlands. s.post@umcutrecht.nl

Insights

Systemic circulating cells aid heart repair after myocardial infarction. Understanding cell mobilization and homing is key for developing effective cell-based cardiac regeneration therapies.

Area of Science:

  • Cardiovascular biology
  • Regenerative medicine
  • Cellular biology

Background:

  • Systemic circulating cells contribute to cardiac maintenance and repair post-myocardial infarction.
  • Limited cell incorporation occurs despite the presence of these cells during cardiac damage.
  • Mobilization, homing, and engraftment of cells are intricate processes influenced by various molecular factors.

Purpose of the Study:

  • To understand the regulation of blood-derived cell mobilization and homing to the ischemic myocardium.
  • To identify cell populations capable of cardiac regeneration or damage reduction after myocardial infarction.
  • To explore modulation strategies for enhancing cell-based cardiac repair therapies.

Main Methods:

  • Review of literature on cell mobilization, homing mechanisms, and cardiac repair.
  • Analysis of factors influencing cell trafficking, including adhesion molecules, proteases, and chemokines.
  • Discussion of physiological, pathophysiological, and pharmacological influences on cell-based therapies.

Main Results:

  • Cellular incorporation into damaged heart tissue is a significant limitation in current cell-based therapies.
  • Mobilization and homing are regulated by a complex interplay of molecular and environmental factors.
  • Specific cytokines, chemokines, and drugs can modulate these cellular processes.

Conclusions:

  • A comprehensive understanding of cell mobilization and homing regulation is crucial for advancing cardiovascular regeneration.
  • Identifying specific cell populations and optimizing their homing is essential for successful cell-based myocardial infarction therapies.
  • Modulating these processes offers a promising avenue for improving cardiac repair outcomes.